Bokf, Na Takeda Pharmaceutical CO LTD Transaction History

Bokf, Na

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $5,667 - $6,136	-408 Reduced 89.08%	50 $0
Q3 2023 Nov 14, 2023	BUY	$15.03 - $16.32 $6,883 - $7,474	458 New	458 $7,000
Q1 2023 May 11, 2023	BUY	$15.28 - $16.48 $12,162 - $13,118	796 New	796 $13,000
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $132,006 - $295,467	10,313 New	10,313 $134,000
Q3 2019 Nov 13, 2019	SELL	$16.15 - $17.99 $166,619 - $185,602	-10,317 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $298 - $368	-18 Reduced 0.17%	10,317 $183,000
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $172,594 - $222,409	10,335 New	10,335 $211,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.